Endoscopic findings in a mass screening program for gastric cancer in a high risk region - Guilan province of Iran

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1407-1412

  Mansour Ghanaei, Fariborz ^a   Sokhanvar, Homayoon ^a   Joukar, Farahnaz ^a   Shafaghi, Afshin ^a   Yousefi Mashhour, Mahmud ^a   Valeshabad, Ali Kord ^c   Fakhrieh, Saba ^b   Aminian, Keyvan ^b   Ghorbani, Kambiz ^b   Taherzadeh, Zahra ^b   Sheykhian, Mohammad Reza ^b   Rajpout, Yaghoub ^b   Mehrvarz, Alireza ^d  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Afrapathobiology Laboratory   (Iran)

Author keywords

Endoscopy; Gastric cancer; Guilan; Iran; Screening

Indexed keywords

UREASE;

ADENOCARCINOMA; AGED; ARTICLE; BIOPSY; DUODENUM ULCER; ENZYMOLOGY; ESOPHAGUS TUMOR; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIATUS HERNIA; HUMAN; IRAN; MALE; MASS SCREENING; MIDDLE AGED; PATHOLOGY; PRECANCER; SQUAMOUS CELL CARCINOMA; STATISTICS; STOMACH; STOMACH TUMOR; STOMACH ULCER;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; DUODENAL ULCER; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERNIA, HIATAL; HUMANS; IRAN; MALE; MASS SCREENING; MIDDLE AGED; PRECANCEROUS CONDITIONS; STOMACH; STOMACH NEOPLASMS; STOMACH ULCER; UREASE;

EID: 84873036977     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1407     Document Type: Article

References (38)

1. Babaei M, Pourfarzi F, Yazdanbod A, et al (2010). Gastric cancer in Ardabil, Iran-a review and update on cancer registry data. Asian Pac J Cancer Prev, 11, 595-9.
2. Choi KS, Kwak MS, Lee HY, et al (2009). Screening for gastric cancer in Korea: population-based preferences for endoscopy versus upper gastrointestinal series. Cancer Epidemiol Biomarkers Prev, 18,1390-8.
3. Ferlay J, Bray F, Pisani P, et al (2004). GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, Version 2.0.IARC Cancer Base no 5. Lyon: IARC Press, (http://www-depdb.iarc.fr/globocan2002.htm).
4. Fock KM, Talley N, Moayyedi P, et al (2008). Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol, 23, 351-65.
5. Ghadimi R, Taheri H, Suzuki S, et al (2007). Host and environmental factors for gastric cancer in Babol, the Caspian Sea Coast, Iran. Eur J Cancer Prev, 16, 192-5.
6. González CA, Pera G, Agudo A, et al (2003). Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer, 107, 629-34.
7. Green PH, O'Toole KM, Slonim D, Wang T, Weg A (1988). Increasing incidence and excellent survival of patients with early gastric cancer: experience in a United States medical center. Am J Med, 85, 658-61.
8. Hussein NR(2010). Helicobacter pylori and gastric cancer in the Middle East: a new enigma? World J Gastroenterol, 16, 3226-34.
9. Kang JM, Kim N, Yoo JY, et al (2008). The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter, 13, 146-56.
10. Khedmat H, Panahian M, Mashahdian M, et al (2011). Prognostic factors and survival in stomach cancer - analysis of 15 years of data from a referral hospital in Iran and evaluation of international variation. Onkologie, 34, 178-82.
11. Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H (2010). Five common cancers in Iran. Arch Iran Med, 13,143-6.
12. Lee HY, Park EC, Jun JK, Choi KS, Hahm MI (2010). Comparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in Korea. World J Gastroenterol, 16, 245-50.
13. Lee KJ, Inoue M, Otani T, et al (2006). Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer, 118, 2315-21.
14. Leung WK, Wu MS, Kakugawa Y, et al (2008). Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol, 9, 279-87.
15. Liou JM, Lin JT, Wang HP, et al (2005). The optimal age threshold for screening upper endoscopy for uninvestigated dyspepsia in Taiwan, an area with a higher prevalence of gastric cancer in young adults. Gastrointest Endosc, 61, 819-25.
16. Malekzadeh R, Derakhshan MH, Malekzadeh Z (2009). Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 12, 576-83.
17. Malekzadeh R, Sotoudeh M, Derakhshan MH, et al (2004). Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol, 57, 37-42.
18. Miyamoto A, Kuriyama S, Nishino Y, et al (2007). Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based study. Prev Med, 44, 12-9.
19. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med, 12, 15-23.
20. Mousavi SM, Somi MH (2009). Gastric cancer in Iran 1966-2006. Asian Pac J Cancer Prev, 10,407-12.
21. Mousavi SM, Ramazani R, Davanloo M, et al (2008a). National Cancer Registry Report 2005-2006. Ministry of Health, Deputy to Health Directory, Tehran, Iran; CDC_ Cancer Office.
22. Mousavi SM, Alamolhoda AA, Gouya MM, Lickiss NJ (2008b). Implementation of comprehensive national cancer control program in Iran: an experience in a developing country. Ann Oncol, 19, 398-400.
23. Mousavi SM (2007). Comprehensive National Cancer Control Program in Iran. Ministry of Health, Deputy to Health Directory, Tehran, Iran; CDC_ Cancer Office.
24. Mukoubayashi C, Yanaoka K, Ohata H, et al (2007). Serum pepsinogen and gastric cancer screening. Intern Med, 46, 261-6.
25. Murakami R, Tsukuma H, Ubukata T, et al (1990). Estimation of validity of mass screening program for gastric cancer in Osaka, Japan. Cancer, 65, 1255-60.
26. Naghavi M, Jafari N (2007). Mortality views in 29 Provinces of Iran in 2004- Ministry of Health, Deputy for Health Directory, Research and Development Office, Tehran, Iran, (in Persian).
27. Naghavi M (2006). Mortality views in 29 Provinces of Iran in 2004- Ministry of Health, Deputy for Health Directory, Res & Development Office, 111-91.
28. Nakamura K, Ueyama T, Yao T, et al (1992). Pathology and prognosis of gastric carcinoma: findings in 10,000 patients who underwent primary gastrectomy. Cancer, 70, 1030-7.
29. Pakseresht M, Forman D, Malekzadeh R, et al (2011). Dietary habits and gastric cancer risk in north-west Iran. Cancer Causes Control, 22, 725-36.
30. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. Sadjadi A, Malekzadeh R, Derakhshan MH, et al(2003). Cancer occurrence in Ardabil: Results of a population-based cancer registry from Iran. Int J Cancer, 107, 113-8.
31. Sadjadi A, Malekzadeh R, Derakhshan MH, et al(2003). Cancer occurrence in Ardabil: Results of a population-based cancer registry from Iran. Int J Cancer, 107, 113-8.
32. Sadjadi A, Zahedi MJ, Darvish Moghadam S, et al (2007). The First population-based cancer survey in Kerman Province of Iran. Iranian J Publ Health, 36, 26-34.
33. Sotoudeh M, Derakhshan MH, Abedi-Ardakani B, et al (2008). Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer. Dig Dis Sci, 53, 27-33.
34. Staël VHC, Eriksson S, Huldt B, Hammar E (1991). Endoscopic screening during 17 years for gastric stump carcinoma: a prospective clinical trial. Scand J Gastroenterol, 26, 1020-6.
35. The EUROGAST Study Group et al (1993). An international association between Helicobacter pylori infection and gastric cancer. Lancet, 341, 1359-62.
36. Tusbono Y, Hisamichi S (2000). Screening for gastric cancer in Japan. Gastric Cancer, 3, 9-18.
37. Wang FW, Tu MS, Mar GY, et al (2011). Prevalence and risk factors of asymptomatic peptic ulcer disease in Taiwan. World J Gastroenterol, 17, 1199-203.
38. Yoshihara M, Hiyama T, Yoshida S, et al (2007). Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study. Scand J Gastroenterol, 42, 760-4.